Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
11.72Price to Sales
VS
Market
Sector
Industry
History
$ 8.22Close
$ 1.9 - $ 14.3 52-Week Range
Ticker Information
Ticker
CRVOCompany Name
CERVOMED INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCERVOMED INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRVO - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 91.14M | 11.72 | $ 7.78M |
| 3/31/2025 | $ 79.19M | 8.51 | $ 9.31M |
| 12/31/2024 | $ 78.76M | 8.09 | $ 9.74M |
| 9/30/2024 | $ 97.64M | 9.7 | $ 10.07M |
| 6/30/2024 | $ 93.1M | 9.64 | $ 9.65M |
| 3/31/2024 | $ 203.87M | 32.03 | $ 6.36M |
| 12/31/2023 | $ 143.77M | 20.12 | $ 7.14M |
| 9/30/2023 | $ 55.21M | 36.17 | $ 1.53M |
| 6/30/2023 | $ 6.64M | 0 | $ 0 |
| 3/31/2023 | $ 8.1M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- CERVOMED INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, CERVOMED INC's average P/S has been 17.
- The median P/S for CERVOMED INC during this period was 10.71
- CERVOMED INC reached its highest P/S over the past 5 years at 36.17.
- The lowest P/S recorded by CERVOMED INC in the same timeframe 8.09
CERVOMED INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for CERVOMED INC is calculated as follows: Market Cap [ $ 49.87M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] CRVO - Price to Sales, Last 5 years
8.09
Minimum
Dec 31, 2024
36.17
Maximum
Sep 30, 2023
17
Average
10.71
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |